1205 related articles for article (PubMed ID: 26269170)
21. Coxsackievirus B3 induces apoptosis in the early phase of murine myocarditis: a comparative analysis of cardiovirulent and noncardiovirulent strains.
Joo CH; Hong HN; Kim EO; Im JO; Yoon SY; Ye JS; Moon MS; Kim D; Lee H; Kim YK
Intervirology; 2003; 46(3):135-40. PubMed ID: 12867750
[TBL] [Abstract][Full Text] [Related]
22. IL-22-producing Th22 cells play a protective role in CVB3-induced chronic myocarditis and dilated cardiomyopathy by inhibiting myocardial fibrosis.
Guo Y; Wu W; Cen Z; Li X; Kong Q; Zhou Q
Virol J; 2014 Dec; 11():230. PubMed ID: 25547181
[TBL] [Abstract][Full Text] [Related]
23. Coxsackievirus B3 induces viral myocarditis by upregulating toll-like receptor 4 expression.
Zhao Z; Cai TZ; Lu Y; Liu WJ; Cheng ML; Ji YQ
Biochemistry (Mosc); 2015 Apr; 80(4):455-62. PubMed ID: 25869363
[TBL] [Abstract][Full Text] [Related]
24. Calpain regulates CVB3 induced viral myocarditis by promoting autophagic flux upon infection.
Meng Y; Sun T; Wu C; Dong C; Xiong S
Microbes Infect; 2020; 22(1):46-54. PubMed ID: 31319178
[TBL] [Abstract][Full Text] [Related]
25. Antiviral activity of coxsackievirus B3 3C protease inhibitor in experimental murine myocarditis.
Yun SH; Lee WG; Kim YC; Ju ES; Lim BK; Choi JO; Kim DK; Jeon ES
J Infect Dis; 2012 Feb; 205(3):491-7. PubMed ID: 22207647
[TBL] [Abstract][Full Text] [Related]
26. Treatment of coxsackievirus-B3-infected BALB/c mice with the soluble coxsackie adenovirus receptor CAR4/7 aggravates cardiac injury.
Dörner A; Grunert HP; Lindig V; Chandrasekharan K; Fechner H; Knowlton KU; Isik A; Pauschinger M; Zeichhardt H; Schultheiss HP
J Mol Med (Berl); 2006 Oct; 84(10):842-51. PubMed ID: 16924471
[TBL] [Abstract][Full Text] [Related]
27.
Fu Q; Gao L; Fu X; Meng Q; Lu Z
J Microbiol Biotechnol; 2019 Aug; 29(8):1230-1239. PubMed ID: 31370111
[No Abstract] [Full Text] [Related]
28. Differential macrophage polarization in male and female BALB/c mice infected with coxsackievirus B3 defines susceptibility to viral myocarditis.
Li K; Xu W; Guo Q; Jiang Z; Wang P; Yue Y; Xiong S
Circ Res; 2009 Aug; 105(4):353-64. PubMed ID: 19608981
[TBL] [Abstract][Full Text] [Related]
29. Protective effects of 20(s)-protopanaxtriol on viral myocarditis infected by coxsackievirus B3.
Wang X; Wang Y; Ren Z; Qian C; Li Y; Wang Q; Zhang Y; Zheng L; Jiang J; Yang C; Wang D; Zhang Y; Fan J; Wang Y
Pathobiology; 2012; 79(6):285-9. PubMed ID: 22688124
[TBL] [Abstract][Full Text] [Related]
30. Proteasome inhibition attenuates coxsackievirus-induced myocardial damage in mice.
Gao G; Zhang J; Si X; Wong J; Cheung C; McManus B; Luo H
Am J Physiol Heart Circ Physiol; 2008 Jul; 295(1):H401-8. PubMed ID: 18515649
[TBL] [Abstract][Full Text] [Related]
31. Berberine impairs coxsackievirus B3-induced myocarditis through the inhibition of virus replication and host pro-inflammatory response.
Dai Q; He X; Yu H; Bai Y; Jiang L; Sheng H; Peng J; Wang M; Yu J; Zhang K
J Med Virol; 2021 Jun; 93(6):3581-3589. PubMed ID: 33336842
[TBL] [Abstract][Full Text] [Related]
32. Cardiac fibroblasts aggravate viral myocarditis: cell specific coxsackievirus B3 replication.
Lindner D; Li J; Savvatis K; Klingel K; Blankenberg S; Tschöpe C; Westermann D
Mediators Inflamm; 2014; 2014():519528. PubMed ID: 25374444
[TBL] [Abstract][Full Text] [Related]
33. The adapter protein c-Cbl-associated protein (CAP) protects from acute CVB3-mediated myocarditis through stabilization of type I interferon production and reduced cytotoxicity.
Valaperti A; Nishii M; Liu Y; Yang H; Naito K; Liu PP; Eriksson U
Basic Res Cardiol; 2014 May; 109(3):411. PubMed ID: 24763933
[TBL] [Abstract][Full Text] [Related]
34. MicroRNA-30a Modulates Type I Interferon Responses to Facilitate Coxsackievirus B3 Replication
Li J; Xie Y; Li L; Li X; Shen L; Gong J; Zhang R
Front Immunol; 2020; 11():603437. PubMed ID: 33519812
[TBL] [Abstract][Full Text] [Related]
35. Coxsackievirus B3-induced chronic myocarditis in outbred NMRI mice.
Merkle I; Tonew M; Glück B; Schmidtke M; Egerer R; Stelzner A
J Hum Virol; 1999; 2(6):369-79. PubMed ID: 10774554
[TBL] [Abstract][Full Text] [Related]
36. Development of a new mouse model for coxsackievirus-induced myocarditis by attenuating coxsackievirus B3 virulence in the pancreas.
Pinkert S; Pryshliak M; Pappritz K; Knoch K; Hazini A; Dieringer B; Schaar K; Dong F; Hinze L; Lin J; Lassner D; Klopfleisch R; Solimena M; Tschöpe C; Kaya Z; El-Shafeey M; Beling A; Kurreck J; Van Linthout S; Klingel K; Fechner H
Cardiovasc Res; 2020 Aug; 116(10):1756-1766. PubMed ID: 31598635
[TBL] [Abstract][Full Text] [Related]
37. [Inhibition of virus infection in coxsackievirus-induced myocarditis model by RNA interference].
Yao HL; He F; Xiao ZH; Liu ZW
Bing Du Xue Bao; 2012 Sep; 28(5):527-30. PubMed ID: 23233928
[TBL] [Abstract][Full Text] [Related]
38. [The mechanisms responsible for the therapeutic effects of anti-Fas ligand antibody on viral myocarditis in mice].
Chang H; Han B; Han XZ
Zhonghua Er Ke Za Zhi; 2005 Dec; 43(12):920-4. PubMed ID: 16412356
[TBL] [Abstract][Full Text] [Related]
39. Th17 cells contribute to viral replication in coxsackievirus B3-induced acute viral myocarditis.
Yuan J; Yu M; Lin QW; Cao AL; Yu X; Dong JH; Wang JP; Zhang JH; Wang M; Guo HP; Cheng X; Liao YH
J Immunol; 2010 Oct; 185(7):4004-10. PubMed ID: 20802148
[TBL] [Abstract][Full Text] [Related]
40. NOD2 (Nucleotide-Binding Oligomerization Domain 2) Is a Major Pathogenic Mediator of Coxsackievirus B3-Induced Myocarditis.
Tschöpe C; Müller I; Xia Y; Savvatis K; Pappritz K; Pinkert S; Lassner D; Heimesaat MM; Spillmann F; Miteva K; Bereswill S; Schultheiss HP; Fechner H; Pieske B; Kühl U; Van Linthout S
Circ Heart Fail; 2017 Sep; 10(9):. PubMed ID: 28912259
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
